Section Arrow
FOCL.NASDAQ
- Edap TMS SA
Quotes are at least 15-min delayed:2026/11/20 17:25 EST
After Hours
Last
 2.61
0 (0.00%)
Bid
2.6
Ask
2.78
High 2.61 
Low 2.6 
Volume 106 
Regular Hours (Closed)
Last
 2.61
-0.21 (-7.45%)
Day High 
3.0999 
Prev. Close
2.82 
1-M High
4.4845 
Volume 
143.15K 
Bid
2.6
Ask
2.78
Day Low
2.55 
Open
2.8 
1-M Low
2.8 
Market Cap 
133.16M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.25 
20-SMA 3.73 
50-SMA 4.05 
52-W High 6.4 
52-W Low 2.11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.96/-0.43
Enterprise Value
151.50M
Balance Sheet
Book Value Per Share
0.76
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
70.53M
Operating Revenue Per Share
1.65
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MEDSDataMeds AI Inc1.34+0.6123+84.14%-- 
After Hours 1.5906 +0.2506 +18.70%
CAHCardinal Health272.81+0.47+0.17%35.23PE
After Hours 273.25 +0.44 +0.16%
HSICHenry Schein83.52-1.28-1.51%23.23PE
After Hours 83.52 0 0.00%
CORCencora339.09-2.16-0.63%25.33PE
After Hours 327.0012 -12.0888 -3.57%
MCKMcKesson Corp1,069.43+7.27+0.68%27.41PE
After Hours 1070 +0.57 +0.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.